Cargando…
Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation
SIMPLE SUMMARY: Glioblastoma is the most malignant tumor of the central nervous system. Glioma stem cells are the cause of adverse outcomes such as early recurrence and low overall survival in glioma patients. Targeting glioma stem cells is considered a promising anti-glioma strategy, Although CD39...
Autores principales: | Liu, Bin, Cao, Yufei, Li, Yanyan, Ma, Haifeng, Yang, Mingfei, Zhang, Qiang, Li, Guofeng, Zhang, Kai, Wu, Yue, Zhou, Youxin, Yang, Wei, Sun, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834269/ https://www.ncbi.nlm.nih.gov/pubmed/35159053 http://dx.doi.org/10.3390/cancers14030783 |
Ejemplares similares
-
Role of HC-gp39 in chondrogenesis: upregulation of SOX-9 expression by HC-gp39 in mouse chondrocytes
por: Jacques, C, et al.
Publicado: (2003) -
Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma
por: Sun, Ting, et al.
Publicado: (2022) -
Aggressive invasion is observed in CD133(−)/A2B5(+) glioma-initiating cells
por: SUN, TING, et al.
Publicado: (2015) -
G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells
por: Cao, Yufei, et al.
Publicado: (2023) -
Interleukin-6 upregulates SOX18 expression in osteosarcoma
por: Wu, Zhong, et al.
Publicado: (2017)